The Role of PARP3 in the Formation of Chromosomal Translocations |
Dana-Farber Cancer Institute / Tovah Day, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis |
Mayo Clinic / Shizhen Zhu, MD, PhD |
Young Investigator Grants |
2013 |
Minnesota |
Exosomes as Biomarkers to Monitor Disease Progression and Response to Therapy in Ewing sarcoma |
Children’s Mercy / Glenson Samuel, MD |
Young Investigator Grants |
2014 |
Missouri |
Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors |
University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD |
Young Investigator Grants |
2019 |
Ontario |
Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma |
University of California San Francisco / Zhenyi An, PhD |
Young Investigator Grants |
2015 |
California |
LRP1 and Angiogenesis in Pediatric Malignant Glioma |
Mayo Clinic Jacksonville / Takahisa Kanekiyo, MD, PhD |
Young Investigator Grants |
2013 |
Florida |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD |
Young Investigator Grants |
2014 |
Washington |
NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Takaya Moriyama, MD/PhD |
Young Investigator Grants |
2018 |
Tennessee |
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
|
Children’s Hospital Los Angeles / Theresa Harned, MD |
Young Investigator Grants |
2006 |
California |
Identification and Validation of Differentiation Therapy for Osteosarcoma
|
Dana-Farber Cancer Institute / Katherine Janeway, MD |
Young Investigator Grants |
2008 |
Massachusetts |